bd surepathtm test (Becton Dickinson)
90
Structured Review
Becton Dickinson
bd surepathtm test
Bd Surepathtm Test, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bd+surepathtm/bd+surepathtm+test/us12054790-255-20-23
Average 90 stars, based on 1 article reviews
Bd Surepathtm Test, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/bd+surepathtm/bd+surepathtm+test/us12054790-255-20-23
Average 90 stars, based on 1 article reviews
bd surepathtm test - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
Immunocytochemistry:Article Title: Clinicopathological significance of claspin overexpression and its efficacy as a novel biomarker for the diagnosis of urothelial carcinoma. Article Snippet: We previously reported that claspin is a key regulator in the progression of gastric cancer and renal cell carcinoma.. However, the clinicopathological significance of claspin in urothelial carcinoma (UC) has not been investigated.. We analyzed the expression and distribution of claspin in UC cases by immunohistochemistry. Immunohistochemistry:Article Title: Clinicopathological significance of claspin overexpression and its efficacy as a novel biomarker for the diagnosis of urothelial carcinoma. Article Snippet: We previously reported that claspin is a key regulator in the progression of gastric cancer and renal cell carcinoma.. However, the clinicopathological significance of claspin in urothelial carcinoma (UC) has not been investigated.. We analyzed the expression and distribution of claspin in UC cases by immunohistochemistry. Food & Beverages:Article Title: Management of cytologic material, preanalytic procedures and biobanking in lymph node cytopathology. Article Snippet: .. Thin Prep (Hologic Inc, Marlborough, Massachusetts) and other:Article Title: The Valgent4 protocol: Robust analytical and clinical validation of 11 HPV assays with genotyping on cervical samples collected in SurePath medium. Article Snippet: The VALGENT4 protocol differs from previous VALGENT installments as the sample collection medium is BD SurePathTM (Becton, Dickinson and Company), targets DNA assays only, and exclusively includes only samples from women ≥30 years of age which is concordant with the majority of HPV primary screening guidelines. Article Title: Title Page / Table of Contents Article Snippet: Amanda Herbert (United Kingdom) SY08-3 Using HPV Testing to Improve Cervical Cancer Screening: Cotesting versus HPV Primary Screening Thomas C. Wright Jr. (United States) SY08-4 Recent Progress in Cervical Cancer Screening and Bethesda System in Japan Yuko Sugiyama (Japan) 13:40–15:40 Companion Meeting 3 [Korean Society of Cytopathology]: Recent Advance of Cytology in East Asia Chairs: Atsuhiko Sakamoto (Japan) / Insun Kim ( Korea) CM03-1 History of the K-J Joint Meeting of Diagnostic Cytology Insun Kim (Korea) CM03-2 Aberrant DNA Methylation of DLX4 and SIM1 Genes Is a Predictive Marker for Disease Progression of Uterine Cervical Low-Grade Squamous Intraepithelial Lesion Kiyomi Taniyama (Japan) CM03-3 Cervical Cancer Screening in Korea: Cytopathology in Update of the National Guideline Recommendation Chong Woo Yoo (Korea) CM03-4 Consciousness and Knowledge of Cervical Cancer Screening and HPV Vaccine in Japanese Young Adults Tomomi Yoshida (Japan) Program XI CM03-5 Papillary Thyroid Carcinoma and Its Variants in Fine Needle Aspiration Cytology Chan Kwon Jung (Korea) 16:10–17:40 Companion Meeting 4 [Australian Society of Cytology]: Cervical Cancer Screening in Australia: The Introduction of Primary HPV Screening and Impact of HPV Vaccination Chairs: Andrew S. Field (Australia) / Wendy Raymond (Australia) CM04-1 Cervical Screening in Australia: A Great Success Story Annabelle Farnsworth (Australia) CM04-2 Renewal of the Australian Cervical Screening Program: The Compass Trial Leads the Way with HPV Screening Marion Saville (Australia) CM04-3 HPV Vaccination in Australia: Impact on Cervical Screening Karen Canfell (Australia) Monday, May 30, 2016 Room 4 (303, 3F) 8:00–10:00 Companion Meeting 5 [Singapore Society of Cytology]: Mountains and Molehills in Cytopathology – Mysteries and Myths Chairs: Angela Chong (Singapore) / Sangeeta Mantoo (Singapore) [Opening Remarks] Fernando Schmitt (Luxembourg) CM05-1 Mysteries of Proliferation Anjula Thomas (Singapore) CM05-2 Endoscopic Ultrasound Guided FNA: Deep Seated Mysteries Min En Nga (Singapore) CM05-3 Mountains and Molehills in Cytology – Plural Pleural Problems Angela Chong (Singapore) CM05-4 Tale of Two Tumours – in Head and Neck Cytology Sangeeta Mantoo (Singapore) CM05-5 Concerning A Strange Thyroid Lesion Felik Paulus (Singapore) CM05-6 Fine Needle Aspiration Cytology of Breast Phyllodes Tumours Revisited Tan Puay Hoon (Singapore) CM05-7 The Myths and Mysterious of Cytology Fernando Schmitt (Luxembourg) 12:40–13:30 Luncheon Seminar D: Non-Gynecological Testing with BD SurePathTM Sponsored by Becton, Dickinson and Company. |